Synthesis of libraries of peptide tertiary amides

US10370409B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10370409-B2
Application numberUS-201214354031-A
CountryUS
Kind codeB2
Filing dateOct 25, 2012
Priority dateOct 25, 2011
Publication dateAug 6, 2019
Grant dateAug 6, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure is directed to a novel class of peptide-like oligomers called peptide tertiary amides (PTAs) and a combinatorial library of PTAs along with synthetic routes for the preparation of large combinatorial libraries of these compounds. The peptide tertiary amides provide an exceptional source of high affinity and selective protein ligands that are useful as tools for biological research and as drug leads, among others.

First claim

Opening claim text (preview).

What is claimed is: 1. A process for preparing a peptide tertiary amide of formula (I) or its enantiomer with the opposite stereochemistry at Cα: wherein R 1 is selected from optionally substituted C 1 -C 10 alkyl, optionally substituted aryl, optionally substituted alkaryl, optionally substituted alkoxyl, optionally substituted heteroaryl, arylalkoxyl, optionally substituted acyl, OH, OR′, NH 2 , NHR′, NR′ 2 , SH, SR′, C(O)R′, and an amino acid side chain; R 2 is selected from optionally substituted C 2 -C 10 alkyl, optionally substituted aryl, optionally substituted alkaryl, optionally substituted alkoxyl, optionally substituted heteroaryl, arylalkoxyl, optionally substituted acyl, OH, OR′, NH 2 , NHR′, NR′ 2 , SH, SR′, C(O)R′, and an amino acid side chain; wherein R′ is selected from optionally substituted C 1 -C 10 alkyl, optionally substituted C 1 -C 10 alkenyl, optionally substituted C 1 -C 10 alkynyl, optionally substituted aryl, optionally substituted alkaryl, and optionally substituted acyl; comprising: oxidizing a primary amine of an amino acid of formula (II) with an oxidizing agent followed by treatment with a nucleophilic bromide source to give an optically pure 2-bromo acid of formula (III): wherein the synthesis further comprises a solid or semi-solid phase synthetic step wherein the solid or semi-solid phase synthetic step comprises bonding the 2-bromo acid of formula (III) to the solid-phase bead using a coupling agent in a solvent to give a compound of formula (V) wherein the compound of formula (V) is reacted with an amine of formula (IV) H 2 N—R 2   (IV) to give a compound of formula (VI): and wherein the compound of formula (VI) is further reacted with additional 2-bromo acid of formula (III) followed by an amine of formula (IV) to obtain oligomers of the compound of formula (VI). 2. The process of claim 1 , wherein the oxidizing agent comprises one of nitrous acid and sulfuric acid. 3. The process of claim 1 , wherein the bromide source comprises a chemical selected from the group consisting of potassium bromide, hydrogen bromide, and sodium bromide. 4. The process of claim 1 , wherein the amine of formula (IV) is a primary amine. 5. The process of claim 1 , wherein the peptide tertiary amide comprises at least 90% enantiomeric excess of the (R) enantiomer. 6. The process of claim 1 , wherein the peptide tertiary amide comprises at least 90% enantiomeric excess of the (S) enantiomer. 7. The process of claim 1 , wherein the peptide tertiary amide comprises one or more Cα- and N-substitutions. 8. The process of claim 1 , wherein the solid-phase comprises a bead. 9. The process of claim 8 , wherein the solid-phase comprises a bead having a methionine linker. 10. The process of claim 1 , wherein the solvent is N,N-dimethylformamide. 11. The process of claim 1 , wherein the oligomers of the compound of formula (VI) are released from the bead by cleaving the oligomers from the solid-phase bead by reacting the bound oligomer with cyanogen bromide.

Assignees

Inventors

Classifications

  • Methods of identifying protein-protein interactions in protein mixtures · CPC title

  • C07K7/06Primary

    having 5 to 11 amino acids · CPC title

  • from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines · CPC title

  • having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated (peptides C07K) · CPC title

  • by chemical synthesis · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10370409B2 cover?
The present disclosure is directed to a novel class of peptide-like oligomers called peptide tertiary amides (PTAs) and a combinatorial library of PTAs along with synthetic routes for the preparation of large combinatorial libraries of these compounds. The peptide tertiary amides provide an exceptional source of high affinity and selective protein ligands that are useful as tools for biological…
Who is the assignee on this patent?
Scripps Research Inst
What technology area does this patent fall under?
Primary CPC classification C07K7/06. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).